semaglutide approved by fda Novo Nordisk's weight-loss pill wins approval U.S. FDA finds no evidence
Description
Semaglutide improves blood sugar control and can treat type 2 diabetes

Whilst these effects support weight loss and glycaemic control, they can make consuming adequate protein challenging, potentially leading to muscle loss during weight reduction

Conditions like polycystic ovary syndrome (PCOS), which is linked to hormonal imbalance, are often worse with weight gain and can affect sex drive and fertility

Certain genetic variants in the GLP1R gene (like rs6923761), FTO gene (rs9939609), and MC4R gene (rs17782313) predict individual variations in appetite suppression and weight loss velocity

Some weeks produce dramatic drops while others show gains despite identical behavior
